David S. Tierney

Quantitative assessment of sustained‐release 4‐aminopyridine for symptomatic treatment of multiple sclerosis

S. R. Schwid, Mary Petrie, Michael McDermott et al. · Neurology · 1997 · 190 citations

Randomized Double-Blind Crossover Trial of Fampridine-SR (Sustained Release 4-Aminopyridine) in Patients With Incomplete Spinal Cord Injury

Patrick J. Potter, Keith C. Hayes, Jack L. Segal et al. · Journal of Neurotrauma · 1998 · 83 citations

Spinal Cord Injury, Pain Medicine, Potassium Channel Blockade +11

The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation

C.J. Kenyon, G. Hooper, David S. Tierney et al. · Journal of Controlled Release · 1995 · 36 citations

Gastrointestinal Pharmacology, Release Formulation, Medicine +9

Absorption Characteristics of Sustained‐Release 4‐Aminopyridine (Fampridine SR) in Patients with Chronic Spinal Cord Injury

Jack L. Segal, Keith C. Hayes, Sherry R. Brunnemann et al. · The Journal of Clinical Pharmacology · 2000 · 23 citations

An Evaluation of the Pharmacokinetics and Pharmacodynamics of the Histrelin Implant for the Palliative Treatment of Prostate Cancer

Martin Dineen, David S. Tierney, Petr Kužma et al. · The Journal of Clinical Pharmacology · 2005 · 17 citations

Hydrogel Implant, Urology, Andrology +11